NXTC NextCure, Inc.

$7.65 +3.52%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

NextCure, Inc. (NXTC) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $35 million. Shares last traded at $7.65, 51.0% below their 52-week high. Over the past year the stock is up 48.0%. Net profit margin is -191.0%, below the peer median of -8.9%. Revenue grew 252.6% year over year.

Market Cap

$35M

Shares Out

4.6M

EPS (TTM)

$-41.44

P/E Ratio

—

P/S Ratio

1.56

P/B Ratio

2.88

Dividend / Share

—

Dividend Yield

—

52-Week High

$15.61

52-Week Low

$1.55

Volume

2,233

Avg Vol (3m)

59,083.968

Performance

+26.87%

+44.89%

+139.81%

-40.47%

YTD

-41.91%

+47.97%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. NXTC split history →

Technicals

RSI (14)

63.97

SMA (50)

$5.02

SMA (200)

$9.10

Price vs SMA50

+52.47%

Price vs SMA200

-15.90%

ATR (14)

$0.76

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$22M

Net Income

$-43M

Gross Margin

—

Operating Margin

-196.2%

Net Margin

-191.0%

Return on Equity

-351.9%

Return on Assets

-189.0%

Current Ratio

3.47

Debt / Equity

0.00

Revenue Growth (YoY)

+252.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-4.68	2026-08-06
Q1 2026	$-1.87	2026-05-07
FY 2025	$-19.65	2026-03-05
Q3 2025	$-18.84	2025-11-05
Q2 2026	$-16.05	2026-08-06
Q1 2026	$-4.70	2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

NXTC vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

1.56 / 11.11 med

-86% discount

Net margin vs peers

-191.0% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.